Report cover image

Tissue Plasminogen Activator Market

Publisher Coherent Market Insights
Published Sep 20, 2023
Length 141 Pages
SKU # CMI18238079

Description

Tissue Plasminogen Activator Market, By Drug Type (Alteplase, Reteplase, Tenecteplase), By Application (Ischemic Stroke, Myocardial Infarction, Pulmonary Embolism, Thrombolysis, Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

Tissue plasminogen activator, also known as tissue-type plasminogen activator (tPA), is a serine protease that is present in endothelial cells, the cells that line blood arteries, and is involved in the process of breaking down blood clots (fibrinolysis). Plasminogen is transformed into plasmin by the tPA enzyme. tPA can be employed in studies on embolic or thrombotic stroke.

tPA may be produced by using recombinant biotechnology methods. This kind of tPA is known as recombinant tissue plasminogen activator (rtPA). t-PA is a proteolytic enzyme present in blood and tissues. The primary physiological function of t-PA is the production of plasmin that can break blood clots in the vasculature.

Market Dynamics

Increasing prevalence of ischemic stroke is expected to drive the market growth over frecast period as tissue-type plasminogen activator (tPA) is used to treat ischemic stroke. For instance, in 2022, according to World Stroke Organization (WSO), there are over 7.6 million new ischemic strokes each year worlwide. Ischemic strokes accounted for more than 62% of incident strokes worldwide in 2019. People aged 15 to 49 account for nearly 11% of all ischemic strokes each year.

Moreover, according to the 2022 report from the American Heart Association, there were approximately 244.1 million individuals globally living with ischemic heart disease (IHD) in the year 2020. This condition was found to be more prevalent among males, with approximately 141.0 million affected, compared to females, where the estimated number of affected individuals was 103.1 million.

Key features of the study:
  • This report provides an in-depth analysis of the global tissue plasminogen activator market and provides market size (US$ Bn) and compound annual growth rate (CAGR) for the forecast period (2023–2030), considering 2022 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global tissue plasminogen activator market based on the following parameters– company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Hoffmann-La Roche AG, Boehringer Ingelheim GmbH, CHIESI Farmaceutici S.p.A., Gennova Biopharmaceuticals Ltd, Abbott Laboratories, and Reliance Life Sciences
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • Global tissue plasminogen activator market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global tissue plasminogen activator market
Detailed Segmentation:
  • By Drug Type:
  • Alteplase
  • Reteplase
  • Tenecteplase
  • By Application:
  • Ischemic Stroke
  • Myocardial Infarction
  • Pulmonary Embolism
  • Thrombolysis
  • Others
  • By Region:
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East
  • Africa
  • Company Profiles
  • F. Hoffmann-La Roche AG.
  • Boehringer Ingelheim GmbH
  • CHIESI Farmaceutici S.p.A.
  • Gennova Biopharmaceuticals Ltd
  • Abbott Laboratories
  • Reliance Life Sciences

Table of Contents

141 Pages
1. Research Objective and Assumption
Research Objectives
Assumptions
Abbreviations
2. Market Purview
Report Description
Market Definition and Scope
Executive Summary
Market Snippet, By Drug Type
Market Snippet, By Application
Market Snippet, By Region
Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Drivers
Restraints
Market Opportunities
Impact Analysis
Market Trend
Epidemiology
Key Developments
Regulatory Scenario
PEST Analysis
Pipeline Analysis
Acquisition and Collaboration Scenario
4. Global Tissue Plasminogen Activator Market– COVID-19 Impact Analysis
COVID-19 Epidemiology
Overall Impact on Healthcare Sector
Total Impact of COVID-19 on Global Tissue Plasminogen Activator Market
Government Recommendations
5. Global Tissue Plasminogen Activator Market, By Drug Type, 2018-2030, (US$ Bn)
Introduction
Market Share Analysis, 2023 and 2030 (%)
Y-o-Y Growth Analysis, 2019–2030
Segment Trends
Alteplase
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 -2030, (US$ Bn)
Segment Trends
Reteplase
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Bn)
Segment Trends
Tenecteplase
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Bn)
Segment Trends
6. Global Tissue Plasminogen Activator Market, By Application, 2018–2030, (US$ Bn)
Introduction
Market Share Analysis, 2023 and 2030 (%)
Y-o-Y Growth Analysis, 2019–2030
Segment Trends
Ischemic Stroke
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Bn)
Segment Trends
Myocardial Infarction
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Bn)
Segment Trends
Pulmonary Embolism
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Bn)
Segment Trends
Thrombolysis
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Bn)
Segment Trends
Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Bn)
Segment Trends
7. Global Tissue Plasminogen Activator Market, By Region, 2018–2030, (US$ Bn)
Introduction
Market Share Analysis, 2023 and 2030 (%)
Y-o-Y Growth Analysis, 2019–2030
Segment Trends
North America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2018 –2030, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Application, 2018–2030, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 –2030, (US$ Bn)
U.S.
Canada
Europe
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2018 –2030, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Application, 2018–2030, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 –2030, (US$ Bn)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2018 –2030, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Application, 2018–2030, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 –2030, (US$ Bn)
China
Japan
India
ASEAN
Australia
South Korea
Rest of Asia Pacific
Latin America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2018 –2030, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Application, 2018–2030, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 –2030, (US$ Bn)
Brazil
Mexico
Argentina
Rest of Latin America
Middle East
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2018 –2030, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Application, 2018–2030, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 –2030, (US$ Bn)
GCC
Israel
Rest of Middle East
Africa
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2018 –2030, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Application, 2018–2030, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2018 –2030, (US$ Bn)
North Africa
Central Africa
South Africa
8. Competitive Landscape
Heat Map Analysis
Company Profiles
F. Hoffmann-La Roche AG
Company Overview
Product Portfolio
Key Highlights
Financial Overview
Strategies
Boehringer Ingelheim GmbH
Company Overview
Product Portfolio
Key Highlights
Financial Overview
Strategies
CHIESI Farmaceutici S.p.A.
Company Overview
Product Portfolio
Key Highlights
Financial Overview
Strategies
Gennova Biopharmaceuticals Ltd
Company Overview
Product Portfolio
Key Highlights
Financial Overview
Strategies
Abbott Laboratories
Company Overview
Product Portfolio
Key Highlights
Financial Overview
Strategies
Reliance Life Sciences
Company Overview
Product Portfolio
Key Highlights
Financial Overview
Strategies
9. Section
References
Research Methodology
About us and Sales Contact
*Browse 26 market data tables and 29 figures on “Global Tissue Plasminogen Activator Market”– Global forecast to 2030

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us